论文部分内容阅读
目的:探讨雾化吸入治疗对于小儿呼吸系统疾病的疗效,期待为临床小儿呼吸系统疾病的治疗提供帮助。方法:选取2016年2月-2017年2月来我所治疗的100例小儿呼吸系统疾病患者作为观察对象,并在随机数字抽样法之下将其分为人数均等的AB两组,对A组实施普米克令舒雾化吸入治疗,对B组实施万托林雾化吸入治疗,一段周期后对比两组患者的治疗总体有效率和不良反应率。结果:B组患者的治疗总体有效率(96%)高于A组患者的治疗总体有效率(84%);B组患者的不良反应率(0%)小于A组患者的不良反应率(16%),且以上差异对比均具有统计学上的意义(p<0.05)。结论:对小儿呼吸系统疾病患者实施万托林雾化吸入治疗方法,对于提高治疗疗效具有现实性意义,有利于提高患者的生活质量。
Objective: To investigate the efficacy of nebulized inhalation therapy for pediatric respiratory diseases and look forward to providing help for the treatment of pediatric respiratory diseases. Methods: A total of 100 pediatric patients with respiratory diseases treated in our hospital from February 2016 to February 2017 were selected as observation subjects and divided into two groups according to the random number sampling method. Patients in group A The implementation of pulmicort respiration inhalation therapy, the implementation of Valentino inhalation group B, after a period of comparison of the two groups of patients treated with the overall efficiency and adverse reaction rates. Results: The total effective rate (96%) in group B was higher than that in group A (84%). The adverse reaction rate (0%) in group B was less than that in group A (16% %), And the above differences were statistically significant (p <0.05). Conclusion: It is of practical significance to improve the curative effect of pediatric patients with respiratory diseases due to inhalation of Vanthorine Inhalation, which is beneficial to improve the quality of life of patients.